Forward Pharma A/S Gross Profit

The latest gross profit for FWP is $-190K as of December 2021. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $65B. Investors often review this figure alongside Forward Pharma A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, FWP's gross profit moved from $0 to $-190K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Forward Pharma A/S's operating scale or balance-sheet position.

Against Healthcare companies, FWP currently prints $-190K for gross profit, while the sector average sits near $65B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Forward Pharma A/S's growth, margins, and balance sheet.

A gross profit figure of $-190K for FWP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $65B. Explore the charts below for those layers of context.

After noting FWP's gross profit ($-190K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.